LGND
Ligand Pharmaceuticals Incorporated
$274.88
+$11.74(+4.46%)
82
Overall
75
Value
100
Tech
71
Quality
Market Cap
$3.56B
Volume
609.56K
52W Range
$110.00 - $276.20
Target Price
$271.00
EPS Estimates Overview
| Current Quarter | $1.21 | Next Quarter | $1.61 |
| Current Year | $4.47 | Next Year | $7.81 |
| QoQ Growth | +33.1% | YoY Growth | +74.7% |
| 3Y EPS CAGR | +73.8% | Target Price | $271.00 |
| Consensus | Buy | Upside | -1.4% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LGND | $274.88 | +4.5% | 609.56K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Ligand Pharmaceuticals Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW